HL7/NCPDP Informative Document: Pharmacist Consultation Note, Release 1- US Realm
|
2. Standards Material/Document
|
Informative
|
Feb 27, 2023
|
|
|
|
|
|
|
Pharmacy
|
Feb 27, 2023
|
https://confluence.hl7.org/pages/viewpage.action?pageId=156545329
|
|
|
|
Yes
|
|
not applicable
|
not applicable
|
HL7/NCPDP Informative Document: Pharmacist Consultation Note, Release 1- US Realm
|
HL7/NCPDP Informative Document: Pharmacist Consultation Note, Release 1
|
|
|
1743
|
US Realm
|
2022-09
|
58
|
1
|
45
|
39
|
134
|
Feb 27, 2023
|
https://confluence.hl7.org/download/attachments/79512445/20230226%20Pharmacist%20Consultation%20Note%20for%20publication.docx?version=1&modificationDate=1677520664743&api=v2
|
Scott Robertson
|
|
http://www.hl7.org/documentcenter/public/ballots/2022SEP/reconciliation/recon_hl7_pharm_consult_r1_i1_2022sep.xls
|
No
|
Pharmacy WG
|
Feb 27, 2023
|
|
Cross-Paradigm
|
Clinical and Administrative Domains, Implementation Guides
|
Pharmacy
|
Guidance on the use of C-CDA Consultation Note and C-CDA on FHIR for a Pharmacist Consultation Note
|
Document
|
45. Parent standard
|
HL7 Implementation Guide for CDA® Release 2: Consolidated CDA Templates for Clinical Notes (US Realm) Standard for Trial Use Release 2.1
C-CDA on FHIR 1.1.0 - (FHIR R4) STU Release 1.1 Consultation Note Profile
|
46. Parent Standard Status
|
Active
|
47. Update/replace standard
|
supplemental
|
pharmacy consult note, pharmacist consult note, consultant pharmacist consultation note
|
|
|
Health Care IT
|
Healthcare Institutions (hospitals, long term care, home care, mental health)
|
|
|
|